Filing Flows › Comparisons › RFL vs COYA
Rafael Holdings vs Coya Therapeutics: RFL and COYA compared
Rafael Holdings is the larger company: $244K of revenue in its latest quarter (Q4 FY26) against $244K for Coya Therapeutics (Q2 2026). Coya Therapeutics is growing faster (+49% against -30% a year earlier).
Where the money goes: RFL and COYA
Rafael Holdings (RFL) · Q4 FY26
Rafael Holdings, Q4 FY26: revenue $244K (-30% year over year), net loss $8.9M, operating cash flow −$8.4M. The chart follows the revenue to costs, profit and cash.
Coya Therapeutics (COYA) · Q2 2026
Coya Therapeutics, Q2 2026: revenue $244K (+49% year over year), net loss $6.6M, operating cash flow −$7.4M. The chart follows the revenue to costs, profit and cash.
| Rafael Holdings (RFL) | Coya Therapeutics (COYA) | |
|---|---|---|
| Latest quarter | Q4 FY26 | Q2 2026 |
| Revenue | $244K | $244K |
| Revenue growth, Y/Y | -30% | +49% |
| Operating margin | n/m | n/m |
| Net earnings | −$8.9M | −$6.6M |
| Operating cash flow | −$8.4M | −$7.4M |
Where the revenue comes from
Rafael Holdings
- Product Revenue: $151K (62%)
- Rental – Third Party: $63K (26%)
- Rental – Related Party: $30K (12%)
Questions
Which is bigger, Rafael Holdings or Coya Therapeutics?
Rafael Holdings is the larger company: $244K of revenue in its latest quarter (Q4 FY26) against $244K for Coya Therapeutics (Q2 2026).
Is Rafael Holdings or Coya Therapeutics growing faster?
Coya Therapeutics is growing faster (+49% against -30% a year earlier).
More: Rafael Holdings earnings · how Rafael Holdings makes money · Coya Therapeutics earnings · how Coya Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-K filed Oct 29, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.